OCS Lung System EXPAND II Trial

NATerminatedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

August 27, 2019

Study Completion Date

July 6, 2022

Conditions
Lung Transplantation
Interventions
DEVICE

OCS Lung Preservation

OCS Lung Preservation

Trial Locations (14)

19140

Temple University Hospital, Philadelphia

21287

The Johns Hopkins Hospital, Baltimore

22908

University of Virginia, Charlottesville

27710

Duke University Medical Center, Durham

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

68198

University of Nebraska, Omaha

77030

Baylor St. Luke's Medical Center, Houston

Houston Methodist, Houston

85013

St. Joseph's Hospital and Medical Center, Phoenix

90095

UCLA Medical Center, Los Angeles

94143

University of California, San Francisco, San Francisco

94305

Stanford University Medical Center, Stanford

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT03343535 - OCS Lung System EXPAND II Trial | Biotech Hunter | Biotech Hunter